Last update:

Coronavirus (COVID-19)

Closing in on a universal vaccine: Nasal spray protects mice from respiratory viruses, bacteria and allergens

In the realm of medical advancements, a universal vaccine that can protect against any pathogen has long been a Holy Grail—and about as elusive as a mythological vessel. But Stanford Medicine researchers and collaborators ...

An unexpected limit to SARS-CoV-2's immune defenses reveal a hidden virus trade-off

A new study has revealed that while SARS-CoV-2 can weaken part of the body's early immune response, it may also unintentionally trigger another defense that helps cells fight back. A new collaborative study has revealed a ...

COVID-19 outbreak

Coronavirus disease 2019 (COVID-19) is the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organization Country Office in China on 31 December 2019 and recognised as a pandemic on 11 March 2020.

Reported illnesses have ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases.

More information: WHO, CDC, global cases.

Follow us on Google News for the latest updates on the coronavirus.

Uncovering the evolutionary limits of the COVID-19 virus

A new paper in Genome Biology and Evolution, indicates that while the COVID-19 virus has developed rapidly since 2019, it has done so within limited genetic channels. These genetic limits have remained unchanged. Despite ...

Researchers explore new approach to multivirus drug development

Wanted: a cheap, multipotent treatment for viral infections. Must be able to handle new or unfamiliar strains, or (even better) a broad range of viruses—whatever comes along, in other words. Must be impervious to viral attempts ...

Vaccines facing misinformation spike: WHO experts

Vaccine programs are being challenged by rising misinformation and an uncertain pipeline for research funding, the World Health Organization's immunization experts said Wednesday.

New review points to faster, safer vaccine development

Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This is important in the context of low-resourced health settings, Africa's focus on increasing its vaccine ...